BERLIN (dpa-AFX) - German drug maker Merck KGaA (MKGAY.PK) announced that it is acquiring the remaining stake in Qlight Nanotech Ltd., Jerusalem, Israel, and will hold 100% of the company. Financial details of the transaction were not disclosed.
By exploiting new technologies Merck aims to strengthen its leadership in liquid crystal display materials and growing presence in OLED materials. Qlight Nanotech's novel nanocrystals help to improve color impression and energy efficiency of modern displays.
Merck has invested into Qlight Nanotech in two steps in 2012 and 2013 already before. Qlight Nanotech will remain the quantum materials research hub for the Performance Materials business sector of Merck.
'The acquisition of Qlight Nanotech perfectly fits into our innovation strategy. We have set the basic platforms for growth in our three business sectors to grow organically and driven by innovation. Innovations are our lifeblood,' said Karl-Ludwig Kley, CEO and Chairman of the Executive Board of Merck.
Qlight Nanotech is a spin-off of Yissum, the technology transfer company of the Hebrew University of Jerusalem.
Qlight Nanotech's Jerusalem site will remain the quantum materials research hub for Merck.
Copyright RTT News/dpa-AFX